Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR.

Blood. 2011 Jan 20;117(3):772-9. doi: 10.1182/blood-2010-01-261123. Epub 2010 Oct 12.

PMID:
20940417
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.

King AA, Noetzel M, White DA, McKinstry RC, Debaun MR.

Pediatr Blood Cancer. 2008 Mar;50(3):599-602.

PMID:
17985350
[PubMed - indexed for MEDLINE]
3.

Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman RA, Younkin DP, Gallagher DM, Kinney TR.

Blood. 2002 Apr 15;99(8):3014-8.

PMID:
11929794
[PubMed - indexed for MEDLINE]
Free Article
4.

Big strokes in small persons.

Adams RJ.

Arch Neurol. 2007 Nov;64(11):1567-74. Review.

PMID:
17998439
[PubMed - indexed for MEDLINE]
5.

Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity.

Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG, Bello J, Zimmerman RA, Adams RJ, Brambilla D; STOP Trial.

Arch Neurol. 2001 Dec;58(12):2017-21.

PMID:
11735775
[PubMed - indexed for MEDLINE]
6.

Silent infarcts in young children with sickle cell disease.

Kwiatkowski JL, Zimmerman RA, Pollock AN, Seto W, Smith-Whitley K, Shults J, Blackwood-Chirchir A, Ohene-Frempong K.

Br J Haematol. 2009 Aug;146(3):300-5. doi: 10.1111/j.1365-2141.2009.07753.x. Epub 2009 Jun 4.

PMID:
19500105
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.

Bishop S, Matheus MG, Abboud MR, Cane ID, Adams RJ, Jackson SM, Kalpatthi R.

Blood Cells Mol Dis. 2011 Aug 15;47(2):125-8. doi: 10.1016/j.bcmd.2011.06.002. Epub 2011 Jul 2.

PMID:
21724428
[PubMed - indexed for MEDLINE]
8.

Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, DeBaun MR.

J Pediatr. 2014 May;164(5):1175-1180.e1. doi: 10.1016/j.jpeds.2014.01.001. Epub 2014 Feb 13.

PMID:
24529619
[PubMed - indexed for MEDLINE]
9.

Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ.

Blood. 2012 May 17;119(20):4587-96. doi: 10.1182/blood-2011-02-272682. Epub 2012 Feb 21. Review.

PMID:
22354000
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.

Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M.

Eur J Haematol. 2010 Mar;84(3):259-65. doi: 10.1111/j.1600-0609.2009.01379.x. Epub 2009 Nov 12.

PMID:
19912310
[PubMed - indexed for MEDLINE]
11.

Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease.

Gyang E, Yeom K, Hoppe C, Partap S, Jeng M.

Am J Hematol. 2011 Jan;86(1):104-6. doi: 10.1002/ajh.21901.

PMID:
21117059
[PubMed - indexed for MEDLINE]
12.

Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.

Hulbert ML, Scothorn DJ, Panepinto JA, Scott JP, Buchanan GR, Sarnaik S, Fallon R, Chu JY, Wang W, Casella JF, Resar L, Berman B, Adamkiewicz T, Hsu LL, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun MR.

J Pediatr. 2006 Nov;149(5):710-2.

PMID:
17095350
[PubMed - indexed for MEDLINE]
13.

The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.

Buchanan ID, James-Herry A, Osunkwo I.

J Pediatr Hematol Oncol. 2013 Oct;35(7):543-6. doi: 10.1097/MPH.0b013e318279caae.

PMID:
23211694
[PubMed - indexed for MEDLINE]
14.

Stroke prevention trial in sickle cell anemia.

Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA, et al.

Control Clin Trials. 1998 Feb;19(1):110-29.

PMID:
9492971
[PubMed - indexed for MEDLINE]
15.

Design of the silent cerebral infarct transfusion (SIT) trial.

Casella JF, King AA, Barton B, White DA, Noetzel MJ, Ichord RN, Terrill C, Hirtz D, McKinstry RC, Strouse JJ, Howard TH, Coates TD, Minniti CP, Campbell AD, Vendt BA, Lehmann H, Debaun MR.

Pediatr Hematol Oncol. 2010 Mar;27(2):69-89. doi: 10.3109/08880010903360367.

PMID:
20201689
[PubMed - indexed for MEDLINE]
16.

Cognitive screening examinations for silent cerebral infarcts in sickle cell disease.

DeBaun MR, Schatz J, Siegel MJ, Koby M, Craft S, Resar L, Chu JY, Launius G, Dadash-Zadeh M, Lee RB, Noetzel M.

Neurology. 1998 Jun;50(6):1678-82.

PMID:
9633710
[PubMed - indexed for MEDLINE]
17.

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.

Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430. Review.

PMID:
23140544
[PubMed - indexed for MEDLINE]
Free Article
18.

Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.

Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, DeWitt LD, Gallagher DM, Guarini L, Moser FG, Ohene-Frempong K, Sanchez N, Vichinsky EP, Wang WC, Wethers DL, Younkin DP, Zimmerman RA, DeBaun MR; Cooperative Study of Sickle Cell Disease.

J Pediatr. 2001 Sep;139(3):385-90.

PMID:
11562618
[PubMed - indexed for MEDLINE]
19.

Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.

Rigano P, Pecoraro A, Calvaruso G, Steinberg MH, Iannello S, Maggio A.

Am J Hematol. 2013 Nov;88(11):E261-4. doi: 10.1002/ajh.23531. Epub 2013 Aug 30.

PMID:
23828131
[PubMed - indexed for MEDLINE]
20.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

PMID:
25140956
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk